Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis

Clinical trial NCT02415608 · TERMINATED

Trial details

NCT number: NCT02415608
Sponsor: Jason Robert Gotlib
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Aggressive Systemic Mastocytosis Mast Cell Leukemia Systemic Mastocytosis

Start date: 2015-03-01
Primary completion: 2016-11-04
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.